Thus, immune escape may be achieved by limiting the influx of immune effectors into cancer tissue [7,8] through down-regulation of endothelial adhesion molecules ICAM-1 and VCAM-1 [9,10,11,12]. The gene discussed is ICAM1; the disease is cancer.